Morgan Stanley Avenue Therapeutics, Inc. Transaction History

Morgan Stanley

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.22 - $0.56 $220 - $561	-1,002 Closed	0 $0
Q1 2022 Oct 27, 2022	BUY	$0.22 - $0.96 $220 - $961	1,002 New	1,002 $0
Q1 2022 May 13, 2022	BUY	$0.22 - $0.96 $212 - $929	968 Added 2847.06%	1,002 $0
Q4 2021 Feb 14, 2022	SELL	$0.88 - $1.78 $77 - $156	-88 Reduced 72.13%	34 $0
Q3 2021 Nov 15, 2021	BUY	$1.48 - $2.65 $180 - $323	122 New	122 $0

Ticker ATXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,127,720
Market Cap $10.1M
Description
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was in...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.